Application 065421
- Type
- ANDA
- Sponsor
- MYLAN LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RIFAMPIN | RIFAMPIN | INJECTABLE;INJECTION | 600MG/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 67457-445 | Rifampin | Rifampin | Mylan Institutional LLC | ANDA | Current |
| 67457-445 | Rifampin | Rifampin | Mylan Institutional LLC | ANDA | Current |
| 67457-445 | Rifampin | Rifampin | Mylan Institutional LLC | ANDA | Current |
| 67457-445 | Rifampin | Rifampin | Mylan Institutional LLC | ANDA | Current |
| 67457-445 | Rifampin | Rifampin | Mylan Institutional LLC | ANDA | Current |
| 82449-802 | Rifampin | Rifampin | STERISCIENCE SPECIALTIES PRIVATE LIMITED | ANDA | Current |